相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Evaluation of the Cytotoxic Effect of Pd(2)Spm against Prostate Cancer through Vibrational Microspectroscopies
Raquel C. C. Laginha et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Disruption of Zinc Homeostasis by a Novel Platinum(IV)-Terthiophene Complex for Antitumor Immunity
Xuxian Su et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2023)
Metal complexes induced ferroptosis for anticancer therapy
Shumeng Li et al.
FUNDAMENTAL RESEARCH (2023)
Pd2Spermine Complex Shows Cancer Selectivity and Efficacy to Inhibit Growth of Triple-Negative Breast Tumors in Mice
Martin Vojtek et al.
BIOMEDICINES (2022)
Understanding Drug Sensitivity and Tackling Resistance in Cancer
Jeffrey W. Tyner et al.
CANCER RESEARCH (2022)
Challenges and Opportunities in Cancer Drug Resistance
Richard A. Ward et al.
CHEMICAL REVIEWS (2021)
Triple-negative breast cancer therapeutic resistance: Where is the Achilles' heel?
Xupeng Bai et al.
CANCER LETTERS (2021)
Impact of the Pd(2)Spm (Spermine) Complex on the Metabolism of Triple-Negative Breast Cancer Tumors of a Xenograft Mouse Model
Tatiana J. Carneiro et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Novel Insights into Mice Multi-Organ Metabolism upon Exposure to a Potential Anticancer Pd(II)-Agent
Tatiana J. Carneiro et al.
Metabolites (2021)
Preclinical Pharmacokinetics and Biodistribution of Anticancer Dinuclear Palladium(II)-Spermine Complex (Pd(2)Spm) in Mice
Martin Vojtek et al.
PHARMACEUTICALS (2021)
Survival benefit of platinum-based regimen in early stage triple negative breast cancer: A meta-analysis of randomized controlled trials
Lei Bian et al.
NPJ BREAST CANCER (2021)
Role of Platinums in Triple-Negative Breast Cancer
Filipa Lynce et al.
CURRENT ONCOLOGY REPORTS (2021)
Metallodrug-protein interaction probed by synchrotron terahertz and neutron scattering spectroscopy
Luis Alberto Esteves Batista de Carvalho et al.
BIOPHYSICAL JOURNAL (2021)
Metal-Based Catalytic Drug Development for Next-Generation Cancer Therapy
Zhongxian Fan et al.
CHEMMEDCHEM (2021)
Response of Osteosarcoma Cell Metabolism to Platinum and Palladium Chelates as Potential New Drugs
Ana S. Martins et al.
MOLECULES (2021)
Anticancer Diiron Vinyliminium Complexes: A Structure-Activity Relationship Study
Simona Braccini et al.
PHARMACEUTICS (2021)
Intracellular water as a mediator of anticancer drug action
M. P. M. Marques et al.
INTERNATIONAL REVIEWS IN PHYSICAL CHEMISTRY (2020)
Cytotoxicity of Platinum and Palladium Chelates against Osteosarcoma
Ana S. Martins et al.
CHEMISTRYSELECT (2020)
Necroptosis Induced by Ruthenium(II) Complexes as Dual Catalytic Inhibitors of Topoisomerase I/II
Kai Xiong et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Drug resistance in cancer: mechanisms and tackling strategies
Tanweer Haider et al.
PHARMACOLOGICAL REPORTS (2020)
Synthesis and structure of a new thiazoline-based palladium(II) complex that promotes cytotoxicity and apoptosis of human promyelocytic leukemia HL-60 cells
Javier Espino et al.
SCIENTIFIC REPORTS (2020)
Proteomic analysis of cisplatin- and oxaliplatin-induced phosphorylation in proteins bound to Pt-DNA adducts
Xin Yuan et al.
METALLOMICS (2020)
The hispanic landscape of triple negative breast cancer
Alejandra Zevallos et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)
Triple-negative breast cancer molecular subtyping and treatment progress
Li Yin et al.
BREAST CANCER RESEARCH (2020)
Anticancer activity of palladium-based complexes against triple-negative breast cancer
Martin Vojtek et al.
DRUG DISCOVERY TODAY (2019)
ONS-donor ligand based Pt(II) complexes display extremely high anticancer potency through autophagic cell death pathway
Faiz-Ur Rahman et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
A phase II trial of bevacizumab in patients with recurrent solid tumor brain metastases who have failed whole brain radiation therapy (WBRT).
Priya Kumthekar et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Triple negative breast cancer and platinum-based systemic treatment: a meta-analysis and systematic review
Jessa Gilda P. Pandy et al.
BMC CANCER (2019)
A view on drug resistance in cancer
Neil Vasan et al.
NATURE (2019)
Triple-Negative Breast Cancers: Systematic Review of the Literature on Molecular and Clinical Features with a Focus on Treatment with Innovative Drugs
Anna Diana et al.
CURRENT ONCOLOGY REPORTS (2018)
Comprehensive review on tumour active palladium compounds and structure-activity relationships
Md Nur Alam et al.
COORDINATION CHEMISTRY REVIEWS (2016)
Pharmacodynamic modeling of adverse effects of anti-cancer drug treatment
A. H. M. de Vries Schultink et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Anti-Invasive and Anti-Proliferative Synergism between Docetaxel and a Polynuclear Pd-Spermine Agent
Ana L. M. Batista de Carvalho et al.
PLOS ONE (2016)
Conformational insights and vibrational study of a promising anticancer agent: the role of the ligand in Pd(II)-amine complexes
Sonia M. Fiuza et al.
NEW JOURNAL OF CHEMISTRY (2015)
Triple-negative breast cancer in African-American women: disparities versus biology
Eric C. Dietze et al.
NATURE REVIEWS CANCER (2015)
Systemic treatment strategies for triple-negative breast cancer
Budhi Singh Yadav et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2014)
Platinum resistance in breast and ovarian cancer cell lines
Niels Eckstein
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2011)
Effect of the metal center on the antitumor activity of the analogous dinuclear spermine chelates (PdCl2)2(spermine) and(PtCl2)2(spermine)
Ana S. Soares et al.
LETTERS IN DRUG DESIGN & DISCOVERY (2007)
Cytotoxic activity of metal complexes of biogenic polyamines: Polynuclear platinum(II) chelates
LJ Teixeira et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)